Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dewar H. A., Oliver M. F. Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. Br Med J. 1971 Dec 25;4(5790):784–786. doi: 10.1136/bmj.4.5790.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fyfe T., Baxter R. H., Cochran K. M., Booth E. M. Plasma-lipid changes after myocardial infarction. Lancet. 1971 Nov;2(7732):997–1001. doi: 10.1016/s0140-6736(71)90322-9. [DOI] [PubMed] [Google Scholar]
- Oliver M. F. Hypercholesterolaemia and coronary heart disease: an answer. Br Med J (Clin Res Ed) 1984 Feb 11;288(6415):423–424. doi: 10.1136/bmj.288.6415.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Proudfit W. L., Bruschke A. V., Sones F. M., Jr Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases. Prog Cardiovasc Dis. 1978 Jul-Aug;21(1):53–78. doi: 10.1016/s0033-0620(78)80004-8. [DOI] [PubMed] [Google Scholar]
- Rosenhamer G., Carlson L. A. Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. Atherosclerosis. 1980 Sep;37(1):129–142. doi: 10.1016/0021-9150(80)90100-8. [DOI] [PubMed] [Google Scholar]
- Shanoff H. M., Little J. A., Csima A. Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period. Can Med Assoc J. 1970 Oct 24;103(9):927–931. [PMC free article] [PubMed] [Google Scholar]